The PLAN lab at New York University is recruiting participants who have had a stroke and have apraxia of speech to participate in our clinical trial investigating whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach, will be used during a portion of speech therapy. Enrolled Participants will participate in speech and language assessments, MRI and will receive 24 motor-speech based therapy sessions over a 4 to 6 month period, at no charge. Participants are eligible for $400 in compensation. To learn more about this research please contact Jessica Sholomenko, SLP at (646) 612-0284 or jo2522@nyu.edu or the lab at buchwald-lab@nyu.edu. The PLAN Lab is located at 665 Broadway in Manhattan.

We are looking for participants to try brain stimulation (tDCS) with speech therapy to see if we can improve the outcomes of speech therapy. The speech therapy involves practicing making difficult sounds and sounds combinations. The study takes approximately 6 months and is in-person.

Inclusion: -Right-handed -Monolingual (English) -Single left-hemisphere CVS -A minimum of six months post-stroke -Clinical diagnosis of apaxia of speech -Normal speech perception -Passing score on the hearing screening. Exclusion: -Diagnosis of laryngeal voice disorder -Dysarthria -History of speech impairment prior to CVA -Presence of potential tDCS risk factors: damaged skin at site of stimulation; presence of electricity or magnetically activated implant (included pacemaker), metal in any part of the body, history of medication-resistant epilepsy in the family, past medical hisotry of seizures or unexpected spells of loss of consciousness.

Adam Buchwald

buchwald-lab@nyu.edu

Stroke; Apraxia, Aphasia

Treatment

Apraxia

4-6 months

October 30, 2026

No cost. $400 reimbursement.